The lawsuit against Medtronic alleged the company improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease.
The lawsuit was originally filed under the qui tam, or whistle-blower, provision of the False Claims Act.
Medtronic has agreed to pay the settling states a combined $362,362, which will be distributed to those states’ Medicaid programs.
More articles on healthcare industry lawsuits:
Detroit area physician admits providing medically unnecessary chemotherapy as part of $225M fraud scheme
Gilead Sciences faces False Claims Act case alleging defective-drug fraud
7 recent healthcare industry lawsuits, settlements
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
